Safety Assessment of Autologous Stem Cell Combination Therapy in Patients With Decompensated Liver Cirrhosis: A Pilot Study.
J Clin Exp Hepatol
; 12(1): 80-88, 2022.
Article
en En
| MEDLINE
| ID: mdl-35068788
7-AAD, 7-aminoactinomycin D; AFP, alpha-fetoprotein; CBA, cytokine cytometric bead assay; CLD, chronic liver disease; DMEM-KO, Dulbecco's modified Eagle's Knock out medium; FBS, foetal bovine serum; G-CSF, granulocyte colony-stimulating factor; HSC, haematopoietic stem cell; IL, interleukin; MELD, Model for End-Stage Liver Disease; MNC, mononuclear cell; MSC, mesenchymal stem cell; SOP, standard operating procedure; TJLB, transjugular liver biopsy; USG, ultrasonography; cath-lab, cardiac catheterization laboratory; cirrhosis of liver; combination of stem cells; mesenchymal stem cells; stem cells
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
J Clin Exp Hepatol
Año:
2022
Tipo del documento:
Article
País de afiliación:
India
Pais de publicación:
India